Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Smith & Nephew SNATS, Inc. Common Stock (NY:SNN)

31.31 +0.97 (+3.20%)
Streaming Delayed Price Updated: 1:54 PM EDT, Jun 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Smith & Nephew SNATS, Inc. Common Stock

< Previous 1 2 3 4 Next >
News headline image
Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Earnings Scheduled For February 25, 2025 ↗
 
Via Benzinga
News headline image
Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
New medial stabilized insert for Smith+Nephew’s LEGION™ Total Knee System designed to improve kinematics, stability and procedural versatility
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew awarded contract to provide Negative Pressure Wound Therapy systems to the United States Department of Defense
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
A comparative sNPWT study of 10,000+ C-sections shows PICO™ sNPWT reduces complications and cuts healthcare costs by $728,000 per 1,000 patients
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Study shows patients treated with Smith+Nephew’s CARTIHEAL™ AGILI-C™ Cartilage Repair Implant have an 87% lower relative risk of Total Knee Arthroplasty or Osteotomy at 4 years¹*
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
New report confirms Smith+Nephew’s OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew is pioneering Spatial Surgery – a defining new Sports Medicine category pushing the boundaries of technology and procedural innovation
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Xpeng, Li Auto And Nutanix Are Among Top 12 Large-Cap Gainers Last Week (Feb 24-Feb 28): Are The Others In Your Portfolio? ↗
These large-cap stocks were top performers last week. Heico, Xpeng, Li Auto, Lineage, Erie Indemnity, Lloyds, Unum, FICO, Masimo, Smith & Nephew, AB InBev, and Nutanix all saw significant gains. 
Via Benzinga
News headline image
Smith+Nephew and UFC to host first-of-its-kind medical education course for treatment of injuries in combat sport athletes
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew’s ALLEVYN™ LIFE Sacrum Foam Dressing and LEAF™ Patient Monitoring System receive ‘favorable’ Evidence Bar™ ratings from ECRI for pressure injury prevention
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew introduces CORIOGRAPH™ Pre-Op Planning and Modeling Services for Total Hip Arthroplasty
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew expands AETOS™ Shoulder System with new stemless option for anatomic shoulder arthroplasty
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Estée Lauder, Robinhood, eBay And Other Big Stocks Moving Lower In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
RENASYS™ EDGE Negative Pressure Wound Therapy System wins Red Dot Award for Design
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew partners with JointVue™ for Ultrasound preoperative planning in robotics-assisted surgery
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew raises the bar in knee revisions by launching new LEGION™ Hinged Knee System with OXINIUM™ Technology
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
First cases using Smith+Nephew’s new CATALYSTEM™ Primary Hip System completed; surgeons hail precision, efficiency and reproducibility
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
3D Systems Expands Orthopedic Surgical Planning Portfolio Receiving FDA Clearance for Key Ankle Indications
From 3D Systems Inc.
Via GlobeNewswire
News headline image
Smith+Nephew brings pre-operative planning and accuracy to total ankle replacement with new TOTAL ANKLE Patient-Matched Guides
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
AVITA Medical Names Robin VanDenburgh as SVP of U.S. Commercial Sales
From AVITA Medical
Via GlobeNewswire
News headline image
Smith+Nephew partners with HOPCo to provide AI-powered analytics and solutions to ASC customers
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Best-in-class just got better; Smith+Nephew announces 510(k) clearance of new CATALYSTEM™ Primary Hip System
From Smith & Nephew UK Ltd
Via GlobeNewswire
News headline image
Smith+Nephew is trailblazing a new path for female surgeons with its Orthopaedics for All initiative; a first-of-its-kind global advisory board
From Smith & Nephew UK Ltd
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.